Hainan Helpson Medical & Biotechnology Co., Ltd (Helpson), a wholly-owned subsidiary of China Pharma Holdings, Inc., entered into a Technology Transfer Agreement with Xiaoyan Zhang. Helpson acquired the invention patent for "Prinsepia Utilis Esterol Sublingual Tablets and Method for Its Preparation" (Patent No. 2018102273158) from Xiaoyan Zhang. The transfer price for the patent is $6.93 million. Payment will be made in 12,600,000 restricted common shares of China Pharma Holdings, Inc., valued at $0.55 per share. The transferor or a designated third party will provide relevant technical services, including product research and development, writing of registration materials, and registration application. The shares will be issued as unregistered securities in reliance on the exemption from registration under Regulation S, as the recipient is a non-U.S. person and the transaction was negotiated and consummated offshore. The patent was granted on March 19, 2018, and is valid until March 19, 2038.